# Why Gilead paid $1.68B but left the heavy lifting to Galapagos - Date: 2026-03-24 - Category: Biotech & Life Sciences Gilead Sciences, the Foster City drugmaker best known for antivirals and now pushing deeper into inflammation, is paying a startling amount for Ouro Medicines, a young autoimmune biotech. ---